Annual Revenue
$329.00 M
+$95.34 M+40.80%
December 31, 2024
Summary
- As of March 10, 2025, TGTX annual revenue is $329.00 million, with the most recent change of +$95.34 million (+40.80%) on December 31, 2024.
- During the last 3 years, TGTX annual revenue has risen by +$322.31 million (+4818.58%).
- TGTX annual revenue is now at all-time high.
Performance
TGTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$108.19 M
+$24.31 M+28.98%
December 31, 2024
Summary
- As of March 10, 2025, TGTX quarterly revenue is $108.19 million, with the most recent change of +$24.31 million (+28.98%) on December 31, 2024.
- Over the past year, TGTX quarterly revenue has stayed the same.
- TGTX quarterly revenue is now -34.76% below its all-time high of $165.81 million, reached on September 30, 2023.
Performance
TGTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$329.00 M
+$64.21 M+24.25%
December 31, 2024
Summary
- As of March 10, 2025, TGTX TTM revenue is $329.00 million, with the most recent change of +$64.21 million (+24.25%) on December 31, 2024.
- Over the past year, TGTX TTM revenue has stayed the same.
- TGTX TTM revenue is now -5.11% below its all-time high of $346.73 million, reached on June 30, 2024.
Performance
TGTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TGTX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.8% | 0.0% | 0.0% |
| 3 y3 years | +4818.6% | 0.0% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% | 0.0% |
TGTX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -34.8% | >+9999.0% | -5.1% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -34.8% | >+9999.0% | -5.1% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -34.8% | -100.0% | -5.1% | >+9999.0% |
TG Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $329.00 M(+40.8%) | $108.19 M(+29.0%) | $329.00 M(+24.3%) |
| Sep 2024 | - | $83.88 M(+14.2%) | $264.79 M(-23.6%) |
| Jun 2024 | - | $73.47 M(+15.7%) | $346.73 M(+19.8%) |
| Mar 2024 | - | $63.47 M(+44.4%) | $289.33 M(+23.8%) |
| Dec 2023 | $233.66 M(+8290.0%) | $43.97 M(-73.5%) | $233.66 M(+23.1%) |
| Sep 2023 | - | $165.81 M(+931.6%) | $189.77 M(+689.0%) |
| Jun 2023 | - | $16.07 M(+106.0%) | $24.05 M(+180.6%) |
| Mar 2023 | - | $7.80 M(+9653.8%) | $8.57 M(+207.9%) |
| Dec 2022 | $2.79 M(-58.4%) | $80.00 K(-14.9%) | $2.78 M(-44.6%) |
| Sep 2022 | - | $94.00 K(-84.2%) | $5.03 M(-27.8%) |
| Jun 2022 | - | $594.00 K(-70.5%) | $6.96 M(-12.0%) |
| Mar 2022 | - | $2.02 M(-13.1%) | $7.91 M(+18.3%) |
| Dec 2021 | $6.69 M(+4300.7%) | $2.32 M(+14.3%) | $6.69 M(+51.8%) |
| Sep 2021 | - | $2.03 M(+31.4%) | $4.41 M(+82.5%) |
| Jun 2021 | - | $1.54 M(+94.8%) | $2.41 M(+166.2%) |
| Mar 2021 | - | $793.00 K(+1986.8%) | $907.00 K(+496.7%) |
| Dec 2020 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Sep 2020 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Jun 2020 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Mar 2020 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Dec 2019 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Sep 2019 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Jun 2019 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Mar 2019 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Dec 2018 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Sep 2018 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Jun 2018 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Mar 2018 | - | $38.00 K(0.0%) | $152.00 K(0.0%) |
| Dec 2017 | $152.00 K(0.0%) | $38.00 K(0.0%) | $152.00 K(+0.2%) |
| Sep 2017 | - | $38.00 K(0.0%) | $151.70 K(-0.1%) |
| Jun 2017 | - | $38.00 K(0.0%) | $151.80 K(-0.1%) |
| Mar 2017 | - | $38.00 K(+0.8%) | $151.90 K(-0.1%) |
| Dec 2016 | $152.00 K(-0.3%) | $37.70 K(-1.0%) | $152.00 K(-0.3%) |
| Sep 2016 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Jun 2016 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Mar 2016 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $152.40 K(0.0%) | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Sep 2015 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Jun 2015 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Mar 2015 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Dec 2014 | $152.40 K(0.0%) | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Sep 2014 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Jun 2014 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Mar 2014 | - | $38.10 K(0.0%) | $152.40 K(0.0%) |
| Dec 2013 | $152.40 K(+702.1%) | $38.10 K(0.0%) | $152.40 K(+14.3%) |
| Sep 2013 | - | $38.10 K(0.0%) | $133.30 K(+40.0%) |
| Jun 2013 | - | $38.10 K(0.0%) | $95.20 K(+66.7%) |
| Mar 2013 | - | $38.10 K(+100.5%) | $57.10 K(+200.5%) |
| Dec 2012 | $19.00 K(-99.3%) | $19.00 K(>+9900.0%) | $19.00 K(-99.7%) |
| Dec 2001 | $2.71 M(-49.4%) | - | - |
| Jun 2001 | - | $0.00(-100.0%) | $5.71 M(-20.1%) |
| Mar 2001 | - | $2.71 M(+40.8%) | $7.15 M(+33.3%) |
| Dec 2000 | $5.36 M(+346.6%) | $1.93 M(+79.6%) | $5.36 M(+23.7%) |
| Sep 2000 | - | $1.07 M(-25.2%) | $4.33 M(+21.7%) |
| Jun 2000 | - | $1.43 M(+55.0%) | $3.56 M(+67.5%) |
| Mar 2000 | - | $925.50 K(+2.8%) | $2.13 M(+77.1%) |
| Dec 1999 | $1.20 M(-52.0%) | $900.00 K(+200.0%) | $1.20 M(+300.0%) |
| Sep 1999 | - | $300.00 K(>+9900.0%) | $300.00 K(+200.0%) |
| Jun 1999 | - | $0.00(0.0%) | $100.00 K(-96.2%) |
| Mar 1999 | - | $0.00(-100.0%) | $2.60 M(-3.7%) |
| Dec 1998 | $2.50 M(+2400.0%) | - | - |
| Sep 1998 | - | $100.00 K(-96.0%) | $2.70 M(0.0%) |
| Jun 1998 | - | $2.50 M(+2400.0%) | $2.70 M(+800.0%) |
| Mar 1998 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1997 | $100.00 K(0.0%) | - | - |
| Sep 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Jun 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1996 | $100.00 K | - | - |
| Sep 1996 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Jun 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is TG Therapeutics annual revenue?
- What is the all time high annual revenue for TG Therapeutics?
- What is TG Therapeutics annual revenue year-on-year change?
- What is TG Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for TG Therapeutics?
- What is TG Therapeutics quarterly revenue year-on-year change?
- What is TG Therapeutics TTM revenue?
- What is the all time high TTM revenue for TG Therapeutics?
- What is TG Therapeutics TTM revenue year-on-year change?
What is TG Therapeutics annual revenue?
The current annual revenue of TGTX is $329.00 M
What is the all time high annual revenue for TG Therapeutics?
TG Therapeutics all-time high annual revenue is $329.00 M
What is TG Therapeutics annual revenue year-on-year change?
Over the past year, TGTX annual revenue has changed by +$95.34 M (+40.80%)
What is TG Therapeutics quarterly revenue?
The current quarterly revenue of TGTX is $108.19 M
What is the all time high quarterly revenue for TG Therapeutics?
TG Therapeutics all-time high quarterly revenue is $165.81 M
What is TG Therapeutics quarterly revenue year-on-year change?
Over the past year, TGTX quarterly revenue has changed by $0.00 (0.00%)
What is TG Therapeutics TTM revenue?
The current TTM revenue of TGTX is $329.00 M
What is the all time high TTM revenue for TG Therapeutics?
TG Therapeutics all-time high TTM revenue is $346.73 M
What is TG Therapeutics TTM revenue year-on-year change?
Over the past year, TGTX TTM revenue has changed by $0.00 (0.00%)